Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
Augusto Caraceni is Director of Palliative Care, Pain Therapy and Rehabilitation Departement of the Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Italy, Vice President of the European Association for Palliative Care Research Network (EAPC - RN), Professor of palliative medicine at the Norwegian University of Science and Technology, Trondheim and director of the Dipartimento interaziendale di cure palliative ASL Milano.
Augusto Caraceni, was born in Milan on August, the 8th 1960, where he lives with his wife and two sons. After graduating from medical school at the Università degli Studi di Milano in 1985, he was board certified in Clinical Neurophysiology (1988) and in Neurology (1993) at the Università di Pavia.
While training in pain therapy and in palliative care at the National Cancer Institute of Milan in 1986 with Vittorio Ventafridda, Dr Caraceni participated in the WHO program to test and disseminate the WHO ladder for cancer pain relief. He was also a Clinical Fellow in Neurology and Palliative care at Memorial Sloan-Kettering Cancer Center, in New York in 1994.
His main previous office was the vicepresidency of the European Association of Palliative Care 2006-2010. His clinical and research experience include the palliative treatment of advanced cancer, neurological complications of cancer, cancer pain classification assessment and treatment with particular attention to opioid analgesics, and symptom control with a special interest in delirium.
He is the author of more than 160 scientific articles in indexed journals, on palliative care, cancer pain and cancer care and of more than 80 other publications. With Luigi Grassi, he published the monographic book, “Delirium: acute confusional states in palliative medicine”, Oxford University Press 2nd ed 2011 and is presently responsible of the Cancer pain guidelines development group of the European Association for Palliative Care.